Bruker AXS Closes Private Financing for Structural Genomics.Business/Healthcare Editors MADISON, Wis.--(BUSINESS WIRE)--Jan. 17, 2001 Bruker AXS Bruker AXS is an international instrument manufacturer and supplier. The company is part of Bruker and specialized on Analytical X-Ray Systems. The main parts are the X-Ray diffraction and the X-Ray spectrometry. Inc., a leading global provider of advanced X-ray solutions for the life and advanced materials Advanced Materials is a leading peer-reviewed materials science journal published every two weeks. Advanced Materials includes Communications, Reviews, and Feature Articles from the cutting edge of materials science, including topics in chemistry, physics, sciences, today announced that it has raised $22.5 million in a private financing round. The investment was led by Thomas Weisel Capital Partners, a $1.3 billion private equity fund managed by Thomas Weisel Partners Thomas Weisel Partners Group, Inc. (NASDAQ: TWPG), often shortened to just TWP or TWeisel, is a U.S. middle-market and growth focused investment banking firm based in San Francisco, California. . Other investors include Burrill & Company and Essex Investment Management Company. "We are excited about this investment, which will be used to further increase our already significant in-house research and product development efforts for enabling life science and materials science materials science Study of the properties of solid materials and how those properties are determined by the material's composition and structure, both macroscopic and microscopic. tools based on our X-ray core technologies. We will also invest in the expansion of our global distribution and customer support capabilities," commented Dr. Martin Haase, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Bruker AXS. He continued: "We are presently rolling out proprietary X-ray systems which leapfrog conventional biological crystallography systems in terms of speed and sensitivity. We intend to leverage these technological breakthroughs and first-class customer support with the goal to become the preferred supplier of X-ray solutions for biological crystallography." Frank H. Laukien, the Chairman of Bruker AXS, added: "This investment occurs right as the structural genomics Noun 1. structural genomics - the branch of genomics that determines the three-dimensional structures of proteins genomics - the branch of genetics that studies organisms in terms of their genomes (their full DNA sequences) market is accelerating. Bruker AXS is now well-positioned as an attractive infrastructure partner for structural proteomics content and drug discovery ventures." Dan Dross, partner in private equity at Thomas Weisel Partners, added "We are pleased to be partnering with Bruker AXS which has a strong market position, leading technology, seasoned management team and potential for strong growth. Bruker's next generation X-ray systems for molecular analysis position the company to participate in the growing market for drug design based upon structural proteomics." Bruker AXS is a leading developer and provider of life science and advanced materials research tools based on X-ray technology. The company develops, manufactures and markets worldwide advanced X-ray solutions for the three-dimensional structure determination of biological and chemical compounds, as well as for advanced materials research and analysis. Its diverse customer base includes pharmaceutical and biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. , advanced materials, semiconductor, synthetic polymer Synthetic polymers are often referred to as "plastics", such as the well-known polyethylene and nylon. However, most of them can be classified in at least three main categories: thermoplastics, thermosets and elastomers. , and basic materials companies, as well as university and government research customers. Applications include x-ray crystallography X-ray crystallography, the study of crystal structures through X-ray diffraction techniques. When an X-ray beam bombards a crystalline lattice in a given orientation, the beam is scattered in a definite manner characterized by the atomic structure of the lattice. for structural proteomics, and automated systems for combinatorial materials sciences. Bruker AXS has the most diverse set of x-ray technology platforms for molecular and materials analysis. In the year 2000, Bruker AXS had revenue of more than $65 million. Statements in this press release that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements involve a high degree of risk and uncertainty that exist in the Company's operations and business environment. Such statements are predictions only and actual events or results may differ materially from those projected in such forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. . Factors that could affect actual events or results include risks associated with performance under the Company's agreements with third parties, research and development progress, competitive products and the strength of the Company's patent portfolio. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion